(Q39887655)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

multicenter clinical trial

29 January 2020

main subject

0 references

author

Isabella Sperduti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Antonello Vidiri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Marta Maschio

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Andrea Pace

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

2

Giulio Metro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Alessandra Fabi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Gaetano Lanzetta

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Mariantonia Carosi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Stefano Telera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Michelangelo Russillo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Carmine M Carapella

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Francesco Cognetti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

publication date

30 March 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

209-215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20352471%20AND%20SRC:MED&resulttype=core&format=json

Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients.

29 January 2020

cites work

1 reference

12 December 2020

Sample size tables for exact single-stage phase II designs

1 reference

12 December 2020

Pseudoprogression and MGMT status in glioblastoma patients: implications in clinical practice.

1 reference

12 December 2020

Response criteria for phase II studies of supratentorial malignant glioma

1 reference

12 December 2020

Malignant gliomas in adults

1 reference

12 December 2020

Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule

1 reference

12 December 2020

MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients

1 reference

12 December 2020

Comparative diffusion study of two nitrosoureas: carmustine and fotemustine in normal rat brain, human and rat brain biopsies

1 reference

12 December 2020

Phase II study of fotemustine in recurrent supratentorial malignant gliomas

1 reference

12 December 2020

Fotemustine (Muphoran) in 22 patients with relapses of high-grade cerebral gliomas

1 reference

12 December 2020

Mechanism of action of fotemustine, a new chloroethylnitrosourea anticancer agent: evidence for the formation of two DNA-reactive intermediates contributing to cytotoxicity

1 reference

12 December 2020

Second-line chemotherapy with dacarbazine and fotemustine in nitrosourea-pretreated patients with recurrent glioblastoma multiforme

1 reference

12 December 2020

A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma

1 reference

12 December 2020

Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

1 reference

12 December 2020

Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience

1 reference

12 December 2020

Incidence of early pseudo-progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

1 reference

12 December 2020

Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability

1 reference

12 December 2020